Calcium phosphate delivery vehicles for osteoinductive proteins

Details Calcium phosphate delivery vehicles for osteoinductive proteins Calcium phosphate delivery vehicles for osteoinductive proteins

2011-08-23

2011-08-23

Henley, III, Raymond (Department: 1629)

Drug, bio-affecting and body treating compositions

Inorganic active ingredient containing

Phosphorus or phosphorus compound

C424S717000

Reexamination Certificate

active

08003133

ABSTRACT:
A composition for delivery of osteogenic proteins is disclosed. The composition comprises an osteogenic protein, a calcium phosphate material as a carrier, and an effective amount of an effervescent agent. Methods of making the compositions and methods of using the osteogenic compositions to treat osteoporotic and/or osteopenic bone are also disclosed.

REFERENCES:
patent: 2465357 (1949-03-01), Correll et al.
patent: 3955719 (1976-05-01), Pheulpin
patent: 4159358 (1979-06-01), Hench et al.
patent: 4191747 (1980-03-01), Scheicher
patent: 4563489 (1986-01-01), Urist
patent: 4596574 (1986-06-01), Urist
patent: 4758233 (1988-07-01), Phillips et al.
patent: 4784055 (1988-11-01), Langen et al.
patent: 4851521 (1989-07-01), della Valle et al.
patent: 5013649 (1991-05-01), Wang et al.
patent: 5024841 (1991-06-01), Chu et al.
patent: 5118667 (1992-06-01), Adams et al.
patent: 5124316 (1992-06-01), Antoniades et al.
patent: 5171579 (1992-12-01), Ron et al.
patent: 5256418 (1993-10-01), Kemp et al.
patent: 5308889 (1994-05-01), Rhee et al.
patent: 5324519 (1994-06-01), Dunn et al.
patent: 5324775 (1994-06-01), Rhee et al.
patent: 5328955 (1994-07-01), Rhee et al.
patent: 5352715 (1994-10-01), Wallace et al.
patent: 5356629 (1994-10-01), Sander et al.
patent: 5422340 (1995-06-01), Ammann et al.
patent: 5447725 (1995-09-01), Damani et al.
patent: 5464440 (1995-11-01), Johansson
patent: 5492697 (1996-02-01), Boyan et al.
patent: 5520923 (1996-05-01), Tjia et al.
patent: 5645592 (1997-07-01), Nicolais et al.
patent: 5650176 (1997-07-01), Lee et al.
patent: 5676976 (1997-10-01), Lee et al.
patent: 5752974 (1998-05-01), Rhee et al.
patent: 5789543 (1998-08-01), Ingham et al.
patent: 5935594 (1999-08-01), Ringeisen et al.
patent: 5939323 (1999-08-01), Valentini et al.
patent: 5972368 (1999-10-01), McKay
patent: 6002065 (1999-12-01), Constantz et al.
patent: 6005162 (1999-12-01), Constantz
patent: 6077076 (2000-06-01), Comfort
patent: 6139578 (2000-10-01), Lee et al.
patent: 6699471 (2004-03-01), Radice et al.
patent: 7413753 (2008-08-01), Li et al.
patent: 2002/0187104 (2002-12-01), Li et al.
patent: 2002/0193883 (2002-12-01), Wironen
patent: 2008/0096797 (2008-04-01), Li et al.
patent: 0 058 481 (1982-08-01), None
patent: 0 329 239 (1989-08-01), None
patent: 0 530 804 (1993-03-01), None
patent: 07-0246235 (1995-09-01), None
patent: 11511722 (1999-10-01), None
patent: WO 91/17777 (1991-11-01), None
patent: WO 92/05199 (1992-04-01), None
patent: WO 93/00050 (1993-01-01), None
patent: WO 93/06872 (1993-04-01), None
patent: WO 93/20858 (1993-10-01), None
patent: WO 96/36562 (1996-11-01), None
patent: WO 96/39203 (1996-12-01), None
patent: WO 96/40297 (1996-12-01), None
patent: WO 97/40137 (1997-10-01), None
patent: WO 97/45532 (1997-12-01), None
patent: WO 97/49412 (1997-12-01), None
patent: WO 98/31788 (1998-07-01), None
patent: WO 98/40113 (1998-09-01), None
patent: WO 99/24070 (1999-05-01), None
patent: WO 99/38543 (1999-08-01), None
patent: WO 00/37124 (2000-06-01), None
patent: WO 00/45870 (2000-08-01), None
patent: WO 01/28602 (2001-04-01), None
patent: WO 01/28603 (2001-04-01), None
patent: WO 02/058755 (2002-08-01), None
patent: WO 02/100331 (2002-12-01), None
patent: WO 03/099992 (2003-12-01), None
Campoccia et al., “Semisynthetic Resorbabel Materials from Hyaluronan Esterification”, Biomaterials, 19:2101-27 (1998).
Fleisch, “Bisphosphonates in bone disease, From the Laboratory to the patient”, 3rd Ed., Parthenon Publishing (1997).
Gerhart et al., “Healing of Large Mid-Femoral Segmental Defects in Sheep Using Recombinant Human Bone Morphogenetic Protein (BMP-2)”, Trans. Othop. Res. Soc., 16:172 (1991).
International Preliminary Examination Report for PCT/US2002/17798, dated Jan. 24, 2003.
International Search Report for PCT/US2002/17798, dated Dec. 17, 2002.
Lee et al., “α-BSM®: A Biomimetic Bone Substitute and Drug Delivery Vehicle”, Clin. Orthop. Rel. Res., 367S:S396-S405 (1999).
Leslie M., “Hyaluronic Acid Treatment for Osteoarthritis of the Knee”, Nurse Practitioner, 24:38, 41-8 (1999).
Ohura et al., “Resporation of, and Bone Formation From New β-tricalcium Phosphate-Monocalcium Phosphate Cements”, J. Biomed. Mat. Res., 30:193-200 (1996).
Ohura et al., “Healing of Segmental Bone Defects in Rats Induced by a β-TCP- MCPM Cement Combined with rhBMP-2”, J. Biomed. Mat. Res., 44:168-175 (1999).
Stedman's Medical Dictionary, 25th Ed. p. 38 “air” (1990).
Tona et al., “Extracellular Matrix in Regenerating Rat Sciatic Nerve: A Comparative Study on the Localization of Laminin Hyaluronic Acie, and Chondroitin Sulfate Proteglycans, Including Versican”, J. Histochem. Cytochem., 41:591-599 (1993).
Toriumi et al., “Mandibular Reconstruction With a Recombinant Bone-Inducing Factor”, Arch. Otolaryngol. Head Neck Surg., 117:1101-1112 (1991).
Urist et al., “β-tricalcium Phosphate Delivery System for Bone Morphogenetic Protein”, Clin. Orthoped. Rel. Res., 187:277-280 (1984).
Urist et al., “Clinical Orthopaedics and Related Research”, Clin. Orthoped. Rel. Res., 214:295-304 (1986).
Urist et al., “Bone Morphogenisis in Implants of Insoluble Bone Gelatin”, PNAS, 70:3511 (1973).
Wang, E. E., “Bone Morphognetic Protein-2 Causes Commitment and Differentiation in C3H10T1/2 and 3T3 Cells”, Trends in Biotech., 11:379-383 (1993).
Blom et al., “Transforming growth factor-β1 incorporated during setting in calcium phosphate cement stimulates bone cell differentiation in vitro,”Journal of Biomedical Materials Research, vol. 50, No. 1, pp. 67-74 (2000).
Leroux et al., “Effects of Various Adjuvants (Lactic Acid, Glycerol, and Chitosan) on the injectability of a calcium phosphate cement,”Bone, vol. 26, No. 2, pp. 31S-34S (1999).
Otsuka et aL, “Effect of Sodium Bicarbonate Amount on In Vitro indomethacin release from self-setting carbonated-apatite cement”Pharmaceutical Research, vol. 14, No. 4, pp. 444-449 (1997).
European Search Report dated Nov. 3, 2010, in corresponding EP Application No. 10183027.1.

Affiliated with

Also associated with

Rating

Calcium phosphate delivery vehicles for osteoinductive proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Calcium phosphate delivery vehicles for osteoinductive proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Calcium phosphate delivery vehicles for osteoinductive proteins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2708814